17,195
edits
Changes
no edit summary
'''Patient Selection for Postmortem Chemotherapy'''
----
Candidates for '''postmortem chemotherapy''' most undergo a rigorous selection process during which they must prove their lack of functional status but that they are clearly still "a fighter."<ref>[http://gomerblog.com/2016/11/hospital-morgue/ Hospital Morgue Morning Rounds Initiated After Family Insists Patient “is a Fighter”]</ref> Patients usually must undergo [[Transthoracic Echocardiogram|transthoracic echocardiogram]] (or [[Amazon Echocardiogram|TTE]]) in order to monitor for and avoid cardiotoxicity as is the case with doxorubin for exampledoxorubicin-based '''postmortem chemotherapy''' regimens.
----
If '''postmortem chemotherapy''' continues its current rate of success, then by the end of 2017 100% of decreased patients should remain dead.